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Background: Community-based diabetes screening programs can help sensitize the   population 
and identify new cases. However, the impact of such programs is rarely assessed in high-income 
countries, where concurrent health information and screening opportunities are common 
place.
Intervention and methods: A 2-week screening and awareness campaign was organized as 
part of a new diabetes program in the canton of Vaud (population of 697,000) in Switzerland. 
Screening was performed without appointment in 190 out of 244 pharmacies in the canton at 
the subsidized cost of 10 Swiss Francs per participant. Screening included questions on risk 
behaviors, measurement of body mass index, blood pressure, blood cholesterol, random blood 
glucose (RBG), and A1c if RBG was $7.0 mmol/L. A mass media campaign promoting physi-
cal activity and a healthy diet was channeled through several media, eg, 165 spots on radio, 
billboards in 250 public places, flyers in 360 public transport vehicles, and a dozen articles in 
several newspapers. A telephone survey in a representative sample of the population of the 
canton was performed after the campaign to evaluate the program.
Results: A total of 4222 participants (0.76% of all persons aged $18 years) underwent the 
screening program (median age: 53 years, 63% females). Among participants not treated for 
diabetes, 3.7% had RBG $ 7.8 mmol/L and 1.8% had both RBG $ 7.0 mmol/L and A1c 
$ 6.5. Untreated blood pressure $140/90 mmHg and/or untreated cholesterol $5.2 mmol/L 
were found in 50.5% of participants. One or several treated or untreated modifiable risk factors 
were found in 78% of participants. The telephone survey showed that 53% of all adults in the 
canton were sensitized by the campaign. Excluding fees paid by the participants, the program 
incurred a cost of CHF 330,600.
Conclusion: A community-based screening program had low efficiency for detecting new 
cases of diabetes, but it identified large numbers of persons with elevated other cardiovascular 
risk factors. Our findings suggest the convenience of A1c for mass screening of diabetes, the 
usefulness of extending diabetes screening to other cardiovascular risk factors, and the impor-
tance of a robust background communication campaign.
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Background
Screening of diabetes and several risk factors for cardiovascular disease is recom-
mended in asymptomatic adults, including those with smoking habits, high blood 
pressure, high cholesterol, and obesity.1–5 Screening of these conditions meet several 
criteria for mass screening,6,7 including high prevalence, silent evolution for several 
years, availability of simple diagnostic tests, and effective treatment for detected cases 
(behavioral or pharmacological). Screening programs for these conditions also have Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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limitations,7–10 such as substantial cost, limited participation, 
false-positive cases, possibly false reassurance for negative 
cases, potential for social inequity, and uncertain evidence 
for health benefit associated with early detection in some 
instances.
There is no general consensus on target populations 
and screening tests for diabetes and cardiovascular risk 
factors.4 In addition, the usefulness of diabetes screening in 
the general population has been debated.2,11–15 Despite low 
efficiency of untargeted diabetes screening,14,16 there is a 
case for community-based screening of diabetes and main 
modifiable cardiovascular risk factors, besides advocacy and 
contingency arguments, since most adults harbor at least one 
risk factor for diabetes or cardiovascular disease.17–19
A community-based screening and awareness campaign 
was organized by the health department of the canton of Vaud 
as part of a new comprehensive diabetes program set up in 
response to the growing burden of diabetes. The campaign 
aimed at: (1) identifying new cases of diabetes and other 
uncontrolled cardiovascular risk factors, (2) raising awareness 
of diabetes and healthy lifestyles in the entire population, and 
(3) raising the overall visibility of the new diabetes program. 
The campaign comprised a screening component and an 
awareness component, which were expected to be mutually 
supportive. The fact that both diabetes and other cardiovas-
cular risk factors share common risk behaviors was central 
to health advice given to all participants to the screening.20,21 
Correspondingly, the need for a healthy diet and regular 
physical activity was the core message of the mass media 
campaign targeting the entire population.
While the impact of targeted screening programs is well 
documented,22,23 less information is available on mass screen-
ing programs through community outreach.16,24 The aim of 
this paper is to provide an account of a community-based 
screening program and an accompanying awareness cam-
paign in the canton of Vaud in terms of impact, processes, 
main findings, and costs. These data may be useful to guide 
similar campaigns.
Methods
Overall organization of the campaign
A screening and awareness campaign for diabetes and 
other cardiovascular risk factors (“the campaign”) was 
organized by the health department of the Vaud Canton, 
Switzerland, as part of a new diabetes program (“Programme 
cantonal Diabète”) aimed at improving both primary and 
secondary prevention of diabetes. A working group of key 
stakeholders from several health sectors elaborated the 
campaign   concept, which included two main components: 
(1) a screening   component to take place in pharmacies of the 
canton targeting all adults, and (2) a mass media campaign 
targeting the general adult population of the canton (popula-
tion aged 18 years or above, N = 554,700).
The actual implementation of the campaign was coordi-
nated by one officer from the canton diabetes program during 
the 4 months from May to August 2010 and by two officers 
during the 4 months from September to December 2010 in 
close collaboration with the regional association of phar-
macists (SVPh) and several other partners. The campaign, 
which took place on November 8–20, 2010, was launched 
during a press conference attended by the minister of health 
of the Canton, the main stakeholders of the campaign, and 
the mass media of the canton.
The screening component  
of the campaign
From a total of 244 pharmacies in the canton, 190 (78%) 
participated in the screening component of the campaign, 
including 108 independent pharmacies and 82 pharmacies 
from the three groups of pharmacies. All pharmacies agreed 
to conduct the screening program along a common protocol 
specifically developed for the campaign. A six-page manual 
of procedures was prepared and distributed to all participat-
ing pharmacies. Pharmacists were trained through a 2-hour 
training session attended by around 300 of them, as well 
as through emails and hands-on training provided on site 
(particularly for the utilization of the “A1cNow” test). The 
distribution of the screening equipment to all pharmacies 
was organized centrally.
Questions to the participants enquired about: their age; 
place of residence; number of years elapsed since their last 
medical visit; history of diabetes in their first degree rela-
tives; history of cardiovascular disease in their first degree 
relatives before the age of 60 years; current treatment for 
diabetes, dyslipidemia, or hypertension; number of hours 
since the last meal or beverage before the screening (except 
for water); smoking habits (number of cigarettes per day); 
practice of regular physical activity; and their interest in 
eating healthily.
Weight and height were measured, and optimal weight 
(corresponding to a body mass index of 25 kg/m2) was cal-
culated for each participant. Blood pressure was measured 
after a 5-minute rest in the sitting position. All pharmacies 
had an electronic sphygmomanometer prior to the campaign, 
although not the same models. A second reading was per-
formed if blood pressure was $140/90 mmHg in persons Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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reporting no treatment for hypertension, and the average of 
the two blood pressure readings was considered.
A single finger stick was used for the measurement of 
both random blood glucose (RBG) and total cholesterol. RBG 
was determined in all participants with a glucometer (Accu-
Check, Roche, Basel, Switzerland), which provides readings 
adjusted to plasma values. The coefficient of variation (CV) 
of the test is 3% and 5% for low and high blood glucose val-
ues, respectively. When RBG was $7.0 mmol/L in persons 
unaware of having diabetes, a new finger stick was performed 
and A1c was measured (A1cNow, Bayer). The A1CNow test 
is simple to perform, and results are ready in 5 minutes. The 
CV of the test (including within-day and between-day) are 
3.0% at low level and 4.0% at high level. The test is certified 
by the United States National Glycohemoglobin Standardiza-
tion Program (NGSP). Total cholesterol was determined in 
all participants with a disposable 3-minute test (Chemcard 
Cholesterol, Chematics, North Webster, IN). Results were 
interpreted by matching the color of a strip with one of the six 
color blocks calibrated at 0.64 mmol/L increments between 
3.9 and 7.8 mmol/L. The test is registered by the United States 
Food and Drug Administration.
All results of the screening program, as mentioned above, 
were consigned by the attending pharmacists in an A5-sized 
card given to each participant within a plastic cover. The card 
was designed to allow the entry of readings for RBG and 
other risk factors on future visits. The card also displayed, 
using different colors, normal and borderline cutoff values 
for all tests performed during the screening program, and it 
also included health information on the main cardiovascular 
risk factors and healthy behaviors. Participants also received 
leaflets on diabetes and cardiovascular risk factors produced 
by partners of the campaign (Ligues de la santé, Swiss Cardi-
ology Foundation, Association of Diabetes of Vaud Canton, 
program “Ça marche!”).
Participants were free to decline any part of the screen-
ing. Participants were informed that their results would not 
be communicated to anyone and that it was the participant’s 
decision to communicate results to their doctor. Participants 
were requested to sign a consent form if they agreed that 
their results be used for an aggregate analysis of the results 
of the campaign. Conditional to this agreement, the screen-
ing cards were photocopied and sent to the diabetes program 
center for data entry in an anonymous database. An amount 
of CHF 10 (approximately EUR 8) was charged by the 
pharmacists to each participant. Pharmacists also received 
CHF 10 from the health services for each test performed. 
The total cost for the disposable material utilized for one 
participant,   accounting for one A1c test performed for every 
10 participants, amounted to around CHF 9.
The awareness component of the 
campaign
The mass media campaign was mandated to a leading 
independent communication company (Bleu-Vert Com-
munication, Lausanne, Switzerland), which worked in close 
collaboration with the organizers of the campaign, including 
the information section of the department of health of the 
canton of Vaud. The core message (in French) of the mass 
media campaign was “Don’t nibble your health capital,” 
which appeared in four different visuals showing healthy 
persons engaging in sedentary habits and/or eating unhealthy 
foods. All visuals included one of two main health messages 
(“A lack of physical activity may result in health problems” 
and “Unhealthy eating habits result in health problems”) 
together with an invite for all adults to “screen for diabetes, 
cholesterol and blood pressure in a pharmacy of the canton” 
(Figure 1). The appearance of these health messages was 
designed to echo the layout of health warnings on cigarettes 
packets. A press release announcing the campaign was sent 
to all mass media and news agencies in the canton.
The visuals were displayed using different supports. Large 
billboards were placed in 250 outdoor public places in the 
canton during the 2-week campaign. Other large billboards 
were placed outside and inside of all the participating phar-
macies. Flyers were made available in 360 public transport 
vehicles (buses and trains). Altogether, 12,000 screening 
cards, 2000 posters (A0, A1, A2), and 90,000 flyers were 
printed. Advertisements were placed in several newspapers. 
Advertisement spots were broadcast 165 times in the two 
main local radio stations. Several educational programs on 
diabetes were also organized on radio and TV and in several 
newspapers. Information was provided in the websites of 
the canton department of health (http://www.vd.ch/diabete) 
and other partners (eg, the diabetes association of the Vaud 
canton,” Ligues de la santé,” “Ça marche!” program, etc).
evaluation of the impact of the campaign 
targeting the general population
A leading independent communication company in the 
region (MIS Trend, Lausanne, Switzerland) was mandated 
to perform an opinion poll about the campaign in the adult 
population of the canton of Vaud. Several officers of the com-
pany administered, a few days after the 2-week campaign, a 
computer-assisted telephonic interview to a representative 
sample of 504 inhabitants of the canton aged 18–74 years.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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evaluation of the screening by the 
pharmacists
A few days after the campaign, the association of pharmacists 
of the canton of Vaud organized a Web-based survey among 
the pharmacists who participated in the screening. The survey 
enquired about different features of the screening program 
and how they perceived the participation of the screenees. 
The survey was completed by 106 (56%) of the 190 pharma-
cists who had participated in the screening program.
Results
Screening component
The screening was attended by 4222 persons, ie, 0.76% of 
the population aged $18 years of the canton. Few partici-
pants (2.2%) declined to have their data used for aggregate 
analysis of screening results. Participation was higher 
during the second as compared with the first week (69% 
and 31% of all participants, respectively), with no marked 
difference according to days of the week (approximately 
400–500 persons per day during the second week). Around 
half of the participants were aged 55 years or above (median 
age, 53 years) and 67% were female (Figure 2). Around 
half of the participants had visited a medical doctor during 
the past 12 months. This proportion was slightly higher in 
women than in men and it increased markedly with age 
(Figure 3).
The distribution of glucose impairment categories is 
shown in Table 1. Overall, 1.8% of all participants reported 
being treated for diabetes.
Among persons not treated for diabetes, the prevalence 
of RBG $ 5.6 mmol/L (a criterion for “impaired fasting 
  glucose” if fasting blood glucose [FBG] is used25) was 44.1% 
overall, but the prevalence was only 34% among persons 
reporting having been fasting for $8 hours. The prevalence 
of RBG $ 7.0 mmol/L (a criterion for diabetes if FBG is 
used25) was 8.8%. This proportion was only 3.7% among 
persons reporting having been fasting for $8 hours: this 
figure may represent a “best estimate” of the prevalence of 
undiagnosed diabetes in participants to the screening based 
on blood glucose results (as opposed to A1c results). The 
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Figure 1 Visuals used in the mass media campaign targeting the general public. The visuals were created using pictures from gettyimages® and iStockphotos®.
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prevalence of RBG $ 7.8 mmol/L (a criterion for “elevated 
glucose” if RBG is used25) was 3.7% overall but 5.9% in 
persons having been fasting for ,4 hours. The prevalence 
of RBG $ 11.0 mmol/L (a criterion for diabetes if RBG is 
used25) was 0.4% overall but 0.6% in persons having been 
fasting for less than 4 hours.
A1c, which was expected to have been done in all persons 
not treated for diabetes who had RBG $ 7.0 mmol/L, had 
actually been performed in only 43% of them (152/233). The 
prevalence of A1c $ 6.5 (a criterion for diabetes in fasting 
and nonfasting persons25,26) was 20.4% in persons with 
RBG $ 7.0 mmol/L. Based on this proportion, 72 partici-
pants (ie, 1.8% of all untreated participants) would have had   
A1c $ 6.5 if A1c had been measured in all 355 participants 
who had RBG $ 7.0 mmol/L. This figure is likely our best 
estimate of the prevalence of suspected new cases of diabetes 
in the screening program.
The prevalence of pre-diabetes cannot be reliably 
determined in the screening program because we used 
RBG (and not FBG) and A1c was done only if RBG was 
$7.0 mmol/L (and not in participants with glucose between 
5.6–7.0 mmol/L). Some indication of the prevalence of pre-
diabetes can however be derived from the prevalence of RBG 
ranging between 5.6 and 7.0 mmol/L (a criterion for pre-
diabetes if FBG is used25,26) in the participants having been 
fasting for $8 hours: this proportion was 30.4%. Another 
indication of the prevalence of pre-diabetes could be derived 
from the prevalence of A1c ranging between 5.6 and 6.4 in 
the participants who were not fasting (eg, fast , 4 hours).
The proportion of smokers was virtually identical in 
male and female participants (16.6% versus 16.0%, respec-
tively), and 44% of all participants were overweight or 
obese. Between a quarter and a third of all participants had 
elevated blood pressure or elevated cholesterol and were 
not treated (Table 2), and 50.8% had either or both of these 
untreated conditions. The proportion of untreated persons 
was substantially smaller in older than younger participants. 
A large majority of all participants had one or more treated 
or untreated cardiovascular risk factors.
Based on the survey conducted among the pharmacists 
after the screening campaign, the screening took ,10 minutes 
for 3% of participants, 10–15 minutes for 27%, 15–20 min-
utes for 32%, 20–25 minutes for 20%, 25–30 minutes for 
14%, and .30 minutes for 4%. Pharmacists reported that 
participants had heard about the screening program through 
promotional material from pharmacists (24% of participants), 
advertisements and programs on radio and TV (22%), articles 
in newspapers (13%), billboards in public places (9%), and 
word of mouth (5%). Pharmacists stated that nearly all 
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Figure 3 Distribution of the participants to the screening program according to sex, 
age, and last medical visit.
Table 1 Proportion of participants in the screening program with selected blood glucose impairment categories according to fasting 
duration
Number of hours since last meal/beverage Unknown Total
,4 hours 4–6 hours $7 hours N % N %
N % N % N %
Data on treatment and rgB 1828 595 804 857 4087
Treated for diabetes 32 1.8 11 1.9 12 1.9 12 1.5 70 1.8
Untreated for diabetes 1796 584 792 845 4017
  rBg $ 5.6 960 53.5 184 31.5 270 34.1 358 42.4 1772 44.1
  rBg $ 7.0 233 13.0 29 5.0 29 3.7 64 7.6 355 8.8
  rBg $ 7.8 106 5.9 12 2.1 10 1.3 22 2.6 150 3.7
  rBg $ 11.0 10 0.6 2 0.3 1 0.1 3 0.4 16 0.4
Untreated for diabetes, rBg $ 7.0 and A1c done
  number of participants 95 11 19 27 152
  rBg $ 7.0 and A1c 5.7–6.4 31 32.6 5 45.5 10 52.6 16 59.3 62 40.8
  rBg $ 7.0 and A1c $ 6.5 17 17.9 2 18.2 7 36.8 5 18.5 31 20.4
Abbreviation: rBg, random blood glucose (mmol/L).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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  participants were very satisfied with both the screening and 
the quality of information provided.
Awareness component
The telephone survey conducted shortly after the screening 
campaign showed that the campaign was recalled by 7% of 
adults spontaneously and by 46% of adults passively (ie, with 
aid), hence by a total of 53% of all adults in the canton. Recall 
of the campaign was similar in large versus small towns and 
in men versus women, but it was larger in older than younger 
persons (Figure 4).
Among the 53% of adults who remembered the 
campaign, 61%–63% reported to have been sensitized “a 
lot” or “somehow” to the health promoting messages related 
to a healthy diet and regular physical activity (ie, the mes-
sages targeting the general population). With regards to 
the message advising members of the public to undergo a 
personal screening at a pharmacy to check for diabetes and 
risk factors, 45%–48% said they had been sensitized “a lot” 
or “somehow” (Figure 5). Hence, 33% (ie, 53% × 63%, 
N = 185,000 persons) of all adults in the canton were 
sensitized to the health promoting messages, and 25% (ie, 
53% × 47%, N = 138,000 persons) to the importance of 
undergoing screening.
Table 2 Proportion of participants in the screening program with selected cardiovascular risk factors, according to sex and age
Sex Age Total
Men Women ,55 $55 N %
N % N % N % N %
Total number of participants 1367 2735 2157 1871 4222
hypertension
  Treated for hypertension 188 14.3 333 12.7 90 4.4 423 23.3 521 13.2
  Untreated and BP $ 140/90 466 35.4 569 21.7 436 21.2 589 32.5 1035 26.1
  Untreated and BP $ 160/100 121 9.2 145 5.5 99 4.8 164 9.0 263 6.6
  % untreated among all with hBPa 71.3 63.1 82.9 58.2 66.5
ec
  Treated for cholesterol (Tc) 119 9.1 177 6.8 57 2.8 235 13.1 292 7.4
  Untreated and Tc $ 5.2 453 34.7 939 36.1 619 30.3 748 41.7 1399 35.6
  Untreated and Tc $ 6.2 138 10.6 325 12.5 180 8.8 271 15.1 451 11.5
  % untreated among all with ecb 79.2 84.1 91.6 76.1 82.7
Overweight (kg/m2)
  Body mass index $ 25 774 59.2 948 36.4 837 40.7 866 48.4 1703 44.3
  Body mass index $ 30 177 13.5 247 9.5 208 10.1 210 11.7 418 10.9
  cigarette smoking (yes/no) 221 16.6 429 16.0 405 19.2 233 12.7 638 16.2
One or more of following risk factors (treated and untreated)
  hBP, ec 885 69.1 1505 58.8 951 47.4 1405 79.7 2397 62.2
  hBP, ec, smoking 936 74.2 1672 66.2 1139 57.5 1429 82.1 2616 68.8
  hBP, ec, smoking, BMi $ 25 1044 85.8 1814 74.6 1347 70.9 1468 87.2 2866 78.3
Note: aBP $ 140/90 mmhg or treatment for hypertension; bTc $ 5.2 mmol/L or cholesterol lowering treatment. Percentages with different conditions are calculated based 
on subsamples with no missing data.
Abbreviations: BMi, body mass index; BP, blood pressure; ec, elevated cholesterol; hBP, high blood pressure.
Among the 53% of all adults in the canton who 
  remembered the campaign, 56% of them gathered informa-
tion on the campaign from the billboards in public places, 
38% from advertisements in newspapers, 33% from bill-
boards around pharmacies, 26% from spots on radios, and 
17% from the pharmacists’ newsletters (which were sent at 
regular intervals to all households in the canton).
Table 3 shows selected findings related to perception 
by the general public about diabetes and about screening 
practices from the telephone survey in a representative 
sample of the population aged 18–74 of the canton of 
Vaud. Of note, the figure of 2% of all adults (N = 3700) 
who said they participated to the screening is close to the 
4222 persons who actually participated in the screening 
program.
Budget of the campaign
The main budget items are listed in Table 4. The total 
cost of the campaign amounted to approximately CHF 
332,320 (approximately EUR 258,000). This amount 
does not take into account the CHF 10 fee paid by each 
participant to the pharmacists (CHF 42,000 in total). The 
communication campaign accounted for the largest part 
of the budget.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Figure 4 recall of the mass media campaign by the general public (telephone survey 
of a representative sample of the population aged 18–74 in the canton of Vaud).
Discussion
We found that a 2-week community-based screening 
had a low impact for identifying new cases of diabetes, 
  consistent with results in other community-based screening 
programs in the USA.13,14,16 Only 0.8% of all adults of the 
canton attended the screening, and between 1.8% and 3.7% 
(depending on which diagnostic criterion was used) of all 
persons not already treated for diabetes had a test result 
compatible with diabetes. However, the screening program 
was able to identify a large number of participants who had 
elevated other cardiovascular risk factors: 51% of all partici-
pants had high blood pressure or elevated cholesterol and no 
treatment. As many as 78% of participants had one or more 
treated or untreated risk factors and could benefit from health 
advice given by the pharmacists. The accompanying aware-
ness campaign targeting the entire population succeeded in 
sensitizing approximately half of all adults in the canton.
We used a two-step strategy for diabetes screening: RBG 
in all participants followed by A1c if RBG was $7.0 mmol/L 
in persons unaware of having diabetes. The stepwise approach 
used in this screening program is practical (participants are 
not requested to be fasting) and it minimizes costs (A1c is 
performed for a minority of participants only); however, this 
is not standard practice, and the validity and cost-effective-
ness of such a strategy should be evaluated. Furthermore, the 
small fee that individuals had to pay in order to participate in 
the screening program has likely limited participation rates 
although it is difficult to estimate the magnitude of this bar-
rier. Since it is difficult to interpret the clinical significance 
of RBG (particularly for values in the intermediate range) 
and in view of the low attendance to a mass screening despite 
a strong communication   campaign, a strategy based on A1c 
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Figure 5 Levels of sensitization to different messages among members of the general public who could recall the campaign (telephone survey of a representative sample of 
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only might be preferred for future community-based screen-
ing programs.27 An A1c-only strategy would be supported 
by the facts that (1) A1c is now an established criterion for 
assessing both diabetes and pre-diabetes,25,26 (2) A1c does 
not require fasting blood, and (3) the cost of the A1c test 
(approximately EUR 7–8) is decreasing. Furthermore, a test 
that does not require FBG can also be particularly useful for 
identifying pre-diabetes, which may be more common than 
diabetes,28,29 and considering that effective interventions for 
the prevention of diabetes can be offered to pre-diabetic 
individuals.2,30 However, the validity of the A1c test for mass 
screening needs further appraisal in view of disagreement 
between diagnosis of diabetes based on blood glucose or 
A1c in some studies,31,32 although A1c was found to be a 
good diagnostic tool for diabetes in other studies.33,34 Dis-
agreement between different diagnostic tests for diabetes 
is expected in view of the multifactorial pathophysiology 
of glucose dysfunction and the absence of a true criterion 
standard. Admittedly, differences between test results may 
have profound impact on the classification of the population 
identified as having pre-diabetes and diabetes.
The prevalence of diabetes based on our community-
based screening (1.8% of cases treated + 1.8% of newly 
detected cases) was lower than the 6.6% diabetes prevalence 
at age 35–75 (with 66% of them aware of the diagnosis) in 
a recent examination survey in the same region.29 This dis-
crepancy might reflect both a “healthy participant effect,” 
which may be stronger in this prevention campaign than 
in epidemiological surveys, and nonparticipation of some 
individuals already aware of having diabetes. The prevalence 
of several other cardiovascular risk factors strongly linked 
to socioeconomic status was also substantially lower in this 
screening program than in the population survey,29 respec-
tively 16% versus 27% for the prevalence of smoking and 
44% versus 52% for the prevalence of BMI $ 25. Of note, 
diabetes and pre-diabetes should be defined only on abnormal 
values confirmed on separate occasions. For example, a study 
in the USA showed that the true prevalence of diabetes was 
24% lower than the prevalence estimated based on fasting 
blood sugar measured on only one visit.35
We found that half of all the participants to the screening 
had elevated blood pressure or elevated blood cholesterol and 
were not treated for these conditions. Although not all these 
persons should be treated because their total cardiovascular 
risk might not be elevated,3,36 a substantial proportion of 
them would benefit from medical management. Furthermore, 
nearly 80% of all participants to the screening had one or 
several modifiable risk factors (untreated or treated), and all 
of them would benefit from health advice. These findings 
strongly support the view that community-based screening 
programs of diabetes should include an assessment of all 
major modifiable cardiovascular risk factors, including health 
promoting advice to all participants that cuts across all risk 
Table 4 Broad cost categories for the screening and awareness 
campaign
Item Cost (CHF)
Printing screening cards, leaflets, and billboards 44,800
Posters in 250 public places 33,700
Placement of flyers in 350 public transport vehicles 8,700
Advertisements in three main  
newspapers
20,700
Production and airing of 165 spots on three local  
radio stations
13,900
Fees to communication company 34,700
Screening material and logistics 21,000
Data entry of screening results 5,300
Telephone survey in sample of general population 10,800
State support to pharmacists 45,070
Other expenses 3,650
Working time of project officers 90,000
Total 332,320
Note: The table does not include the chF 10 subsidized fee paid by each participant 
for the screening (a total of chF 42,000).
Table 3 Perception of diabetes and screening practices in the 
general public (telephone survey of a representative sample of the 
population aged 18–74 of the canton of Vaud)
Item Percentage
Severity of diabetes as a disease
  Very severe 33
  Quite severe 61
  not severe 6
Knows someone who has diabetes among relatives
  All 53
Underwent diabetes screening in past 12 months
  All 37
  Men 36
  Women 37
  18–34 16
  35–49 28
  50–64 50
  65–74 65
Among those screened, reason for doing screening
  Own initiative 49
  Advice of a doctor 47
  Pressure from relatives 2
  Screening campaign 2
Where would you find information on a health problema
Age 18–34 Age 64–75
  internet 53 76
  Doctor 72 57
  Pharmacist 8 17
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factors.37 While identification and referral of persons with 
abnormal conditions is the main outcome of any screening 
program, health advice given by a health professional at the 
time of the screening can be highly cost-effective, eg, advice 
to quit smoking.1
Our screening program was accompanied by a strong 
communication campaign targeting the entire adult popula-
tion with the double aim of informing the public about the 
screening and raising awareness on healthy lifestyles in 
the general population. Mass media campaigns that promote 
physical activity and healthy nutrition can have a positive 
impact, although they compete with pervasive product 
marketing, powerful social norms, and behaviors driven by 
addictions or habits.38 Therefore, media campaigns need to 
be organized at a large scale in order to be identified from 
the large flow of information from many concurrent sources. 
Although the “dose” of health education program delivered 
during a 2-week campaign is inherently limited, we cannot 
exclude a beneficial impact considering that half of all adults 
in the canton remembered the campaign and nearly a third 
of them (88,000 persons) reported to have been sensitized 
“a lot.”
It is legitimate to enquire about the potential cost- 
effectiveness of the community-based screening program and 
the related awareness campaign, knowing that “all screen-
ing programs do harm; some do good as well and, of these, 
some do more good than harm at reasonable cost”8 and that 
screening programs entail substantial opportunity costs.13 
We don’t know the actual uptake of health services for those 
participants who had a positive test (diabetes, hypertension, 
dyslipidemia) and no treatment in our screening program – 
which can be very low in other contexts39 – and we know 
that the impact of individual-based advice for increasing 
physical activity or improving nutrition is generally only 
modest.40 However, we could argue that the program could 
be cost-effective if only a small percentage of the approxi-
mately 3000 participants who had one or several risk factors 
adopted a healthier behavior or initiated effective medical 
treatment and/or if a small proportion of the approximately 
88,000 persons in the canton who were much sensitized by 
the mass media campaign had engaged in a healthier life-
style. The campaign could cost less than CHF 300 per person 
adopting a healthy behavior or initiating effective treatment 
if more than 1000 persons (either screenees or members of 
the general public) had made such a change as a result of 
the campaign.
Furthermore, other variables should be factored when 
assessing the impact of community-based screening 
  campaigns. For example, team building and involvement of 
new partners, which cannot be quantified in monetary units, 
are valuable outputs that may eventually turn into important 
resources for further programs tackling chronic diseases. 
In particular, it is increasingly recognized that community 
pharmacists have an important role for the delivery of health 
information to the general public, for the detection of new 
cases, and for improved management of chronic patients.41 
New alliances may also turn into important resources when 
advocating for larger enrollment of the population into pre-
ventive strategies at health services level42 or for structural 
interventions cutting across all sectors for the prevention of 
diabetes and chronic conditions.43–46
The known problems of glucose-based screening with 
regards to valid identification of new diabetes cases, coupled 
with a low yield of new suspected cases, make community 
glucose-based screening unattractive. However, the large 
numbers of persons with abnormal levels of one or more 
cardiovascular risk factors, the increasing availability of 
simple screening tests, and the potential for capacity building 
processes suggest that a community-based screening program 
assessing diabetes together with the main cardiovascular 
risk factors might have acceptable efficiency despite low 
participation.
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